Мягкие неврологические симптомы при шизофрении
Рекомендуемое оформление библиографической ссылки:
Захарова К.В., Аркуша И.А., Файзуллоев А.З., Акжигитов Р.Г., Аведисова А.С. Мягкие неврологические симптомы при шизофрении // Российский психиатрический журнал. 2022. №5. С. 63-73.
В научном обзоре с целью анализа и систематизации данных о мягких неврологических симптомах, обнаруживаемых при шизофрении, был проведён анализ российских и зарубежных исследований за последние 30 лет по электронным информационным ресурсам (библиотека Elsevier, PubMed, Google Scholar). Освещено современное понимание концепции мягких неврологических знаков при их изучении у больных шизофренией, приведены различные методики их обнаружения. Представлены актуальные точки зрения о роли данного феномена в диагностике и прогнозе шизофрении, а также описаны патогенетические концепции мягких неврологических симптомов.
Ключевые слова мягкие неврологические знаки; шизофрения; эндофенотип шизофрении
1. Bachmann S, Degen C, Geider FJ, Schröder J. Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis. Front Psychiatry. 2014;5:185. DOI: https://doi.org/10.3389/fpsyt.2014.00185 2. Quitkin F, Rifkin A, Klein DF. Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Arch Gen Psychiatry. 1976;33(7):845–53. DOI: https://doi.org/10.1001/archpsyc.1976.01770070075008 3. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry. 1986;43(7):657–63. DOI: https://doi.org/10.1001/archpsyc.1986.01800070043006 4. Neelam K, Garg D, Marshall M. A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry. 2011;11:139. DOI: https://doi.org/10.1186/1471-244X-11-139 5. Arbabi M, Paast N, Karim HR, et al. Mild neurological impairment may indicate a psychomotor endophenotype in patients with borderline personality disorder. Psychiatry Res. 2016;245:22–6. DOI: https://doi.org/10.1016/j.psychres.2016.08.006 6. Mrad A, Wassim Krir M, Ajmi I, et al. Neurological soft signs in euthymic bipolar I patients: A comparative study with healthy siblings and controls. Psychiatry Res. 2016;236:173–8. DOI: https://doi.org/10.1016/j.psychres.2015.11.047 7. Ozcan H, Ozer S, Yagcioglu S. Neuropsychological, electrophysiological and neurological impairments in patients with obsessive compulsive disorder, their healthy siblings and healthy controls: Identifying potential endophenotype(s). Psychiatry Res. 2016;240:110–7. DOI: https://doi.org/10.1016/j.psychres.2016.04.013 8. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27(3):335–50. DOI: https://doi.org/10.1016/0165-1781(89)90148-0 9. Rathod B, Kaur A, Basavanagowda DM, et al. Neurological Soft Signs and Brain Abnormalities in Schizophrenia: A Literature Review. Cureus. 2020;12(10):e11050. DOI: https://doi.org/10.7759/cureus.11050 10. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry. 1986;43(7):657–63. DOI: https://doi.org/10.1001/archpsyc.1986.01800070043006 11. Stevens JR, Livermore A. Telemetered EEG in schizophrenia: spectral analysis during abnormal behaviour episodes. J Neurol Neurosurg Psychiatry. 1982;45(5):385–95. DOI: https://doi.org/10.1136/jnnp.45.5.385 12. Boks MP, Russo S, Knegtering R, van den Bosch RJ. The specificity of neurological signs in schizophrenia: a review. Schizophr Res. 2000;43(2–3):109–16. DOI: https://doi.org/10.1016/s0920-9964(99)00145-0 13. Schröder J, Niethammer R, Geider FJ, et al. Neurological soft signs in schizophrenia. Schizophr Res. 1991;6(1):25–30. DOI: https://doi.org/10.1016/0920-9964(91)90017-l 14. Chen EY, Shapleske J, Luque R, et al. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995;56(2):183–204. DOI: https://doi.org/10.1016/0165-1781(95)02535-2 15. Jahn T, Cohen R, Hubmann W, et al. The Brief Motor Scale (BMS) for the assessment of motor soft signs in schizophrenic psychoses and other psychiatric disorders. Psychiatry Res. 2006;142(2–3):177–89. DOI: https://doi/org/10.1016/j.psychres.2002.12.002 16. The Scottish First Episode Schizophrenia Study. I. Patient identification and categorisation. The Scottish Schizophrenia Research Group. Br J Psychiatry. 1987;150:331–3. DOI: https://doi.org/10.1192/bjp.150.3.331 17. Cunningham Owens DG, Johnstone EC. The disabilities of chronic schizophrenia – their nature and the factors contributing to their development. Br J Psychiatry. 1980;136:384–95. DOI: https://doi.org/10.1192/bjp.136.4.384 18. Browne S, Clarke M, Gervin M, et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychological Medicine. 2000;30(6):1433–41. DOI: https://doi.org/10.1017/s003329179900286x 19. Rossi A, De Cataldo S, Di Michele V, et al. Neurological soft signs in schizophrenia. Br J Psychiatry. 1990;157:735–9. DOI: https://doi.org/10.1192/bjp.157.5.735 20. Chan RC, Chen EY. Neurological abnormalities in Chinese schizophrenic patients. Behav Neurol. 2007;18(3):171–81. DOI: https://doi.org/10.1155/2007/451703 21. Whitty P, Clarke M, Browne S, et al. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol Med. 2003;33(8):1479–84. DOI: https://doi.org/10.1017/s0033291703008225 22. Bachmann S, Bottmer C, Schröder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry. 2005;162(12):2337–43. DOI: https://doi.org/10.1176/appi.ajp.162.12.2337 23. Scheffer RE. Abnormal neurological signs at the onset of psychosis. Schizophr Res. 2004;70(1):19–26. DOI: https://doi.org/10.1016/j.schres.2003.10.007 24. Emsley R, Turner HJ, Oosthuizen PP, Carr J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophr Res. 2005;75(1):35–44. DOI: https://doi.org10.1016/j.schres.2004.06.014 25. Mittal VA, Hasenkamp W, Sanfilipo M, et al. Relation of neurological soft signs to psychiatric symptoms in schizophrenia. Schizophr Res. 2007;94(1–3):37–44. DOI: https://doi.org/10.1016/j.schres.2007.04.017 26. Chan RCK, Geng FL, Lui SSY, et al. Course of neurological soft signs in first-episode schizophrenia: Relationship with negative symptoms and cognitive performances. Sci Rep. 2015;5:11053. DOI: https://doi.org/10.1038/srep11053 27. Emsley R, Chiliza B, Asmal L, et al. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects. Schizophr Res. 2017;188:144–50. DOI: https://doi.org/10.1016/j.schres.2017.01.034 28. Prikryl R, Ceskova E, Kasparek T, Kucerova H. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. J Psychiatr Res. 2006;40(2):141–6. DOI: https://doi.org/10.1016/j.jpsychires.2005.03.008 29. Chen EY, Hui CL, Chan RC, et al. A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophr Res. 2005;75(1):45–54. DOI: https://doi.org/10.1016/j.schres.2004.09.002 30. Ojagbemi A, Esan O, Emsley R, Gureje O. Motor sequencing abnormalities are the trait marking neurological soft signs of schizophrenia. Neurosci Lett. 2015;600:226–31. DOI: https://doi.org/10.1016/j.neulet.2015.06.028 31. Whitty P, Clarke M, Browne S, et al. Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychol Med. 2003;33(8):1479–84. DOI: https://doi.org/10.1017/s0033291703008225 32. Wahlheim C, Hubmann W, Mohr F, et al. Prävalenz und Stabilität neurologischer Soft Signs bei schizophrenen Patienten. In: Bräunig P, editor. Motorische Störungen bei schizophrenen Psychosen. Stuttgart, New York: Schattauer; 1999. р. 93–106. DOI: https://doi.org/10.1176/jnp.11.1.91 33. Schröder J, Tittel A, Stockert A, Karr M. Memory deficits in subsyndromes of chronic schizophrenia. Schizophr Res. 1996;21(1):19–26. DOI: https://doi/org/10.1016/0920-9964(96)00027-8 34. Cuesta MJ, Jalón EG, Campos MS, Peralta V. Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. Br J Psychiatry. 2009;194(5):439–45. DOI: https://doi.org/10.1192/bjp.bp.108.055137 35. Whitty P, Clarke M, McTigue O, et al. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophr Res. 2006;86(1–3):110–7. DOI: https://doi.org/10.1016/j.schres.2006.04.012 36. Boks MP, Selten JP, Leask S, Van den Bosch RJ. The 2-year stability of neurological soft signs after a first episode of non-affective psychosis. Eur Psychiatry. 2006;21(5):288–90. DOI: https://doi.org/10.1016/j.eurpsy.2005.09.004 37. Sevincok L, Topaloglu B. Neurological soft signs and positive treatment response to olanzapine in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(1):141–3. DOI: https://doi.org/10.1016/j.pnpbp.2005.06.012 38. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand. 1999;100(2):119–25. DOI: https://doi.org/10.1111/j.1600-0447.1999.tb10832.x 39. Smith RC, Hussain MI, Chowdhury SA, Stearns A. Stability of neurological soft signs in chronically hospitalized schizophrenic patients. J Neuropsychiatry Clin Neurosci. 1999;11(1):91–6. DOI: https://doi.org/10.1176/jnp.11.1.91 40. Prikryl R, Ceskova E, Tronerova S, et al. Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia. Psychiatry Res. 2012;200(2–3):67–72. DOI: https://doi.org/10.1016/j.psychres.2012.03.008 41. Prikryl R, Ceskova E, Kasparek T, Kucerova H. Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia. Eur Psychiatry. 2007;22(8):499–504. DOI: https://doi.org/10.1016/j.eurpsy.2007.03.012 42. Chan RC, Gottesman II. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star? Neurosci Biobehav Rev. 2008;32(5):957–71. DOI: https://doi.org/10.1016/j.neubiorev.2008.01.005 43. Meehl P. Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia. J Pers Disord. 1990;4(1):1–99. DOI: https://doi.org/10.1521/pedi.1990.4.1.1 44. Wolff AL, O'Driscoll GA. Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk. J Psychiatry Neurosci. 1999;24(4):304–14. PMID: 10516797 45. Niethammer R, Weisbrod M, Schiesser S, et al. Genetic influence on laterality in schizophrenia? A twin study of neurological soft signs. Am J Psychiatry. 2000;157(2):272–4. DOI: https://doi.org/10.1176/appi.ajp.157.2.272 46. Kelly BD, Cotter D, Denihan C, et al. Neurological soft signs and dermatoglyphic anomalies in twins with schizophrenia. Eur Psychiatry. 2004;19(3):159–63. DOI: https://doi.org/10.1016/j.eurpsy.2003.10.006 47. Picchioni MM, Toulopoulou T, Landau S, et al. Neurological abnormalities in schizophrenic twins. Biol Psychiatry. 2006;59(4):341–8. DOI: https://doi.org/10.1016/j.biopsych.2005.07.007 48. Lawrie SM, Byrne M, Miller P, et al. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry. 2001;178:524–30. DOI: https://doi.org/10.1192/bjp.178.6.524 49. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988;145(1):11–8. DOI: https://doi.org/10.1176/ajp.145.1.11 50. Cantor-Graae E, McNeil TF, Rickler KC, et al. Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma? Am J Psychiatry. 1994;151(8):1194–9. DOI: https://doi.org/10.1176/ajp.151.8.1194 51. Arbabi M, Paast N, Karim HR, et al. Mild neurological impairment may indicate a psychomotor endophenotype in patients with borderline personality disorder. Psychiatry Res. 2016;245:22–6. DOI: https://doi.org/10.1016/j.psychres.2016.08.006 52. Mrad A, Wassim Krir M, Ajmi I, et al. Neurological soft signs in euthymic bipolar I patients: A comparative study with healthy siblings and controls. Psychiatry Res. 2016;236:173–8. DOI: https://doi.org/10.1016/j.psychres.2015.11.047 53. Ozcan H, Ozer S, Yagcioglu S. Neuropsychological, electrophysiological and neurological impairments in patients with obsessive compulsive disorder, their healthy siblings and healthy controls: Identifying potential endophenotype(s). Psychiatry Res. 2016;240:110–7. DOI: https://doi.org/10.1016/j.psychres.2016.04.013 54. Bachmann S, Schröder J. Neurological Soft Signs in Schizophrenia: An Update on the State-versus Trait-Perspective. Front Psychiatry. 2018;8:272. DOI: https://doi.org/10.3389/fpsyt.2017.00272 55. Crow TJ, Done DJ, Sacker A. Childhood precursors of psychosis as clues to its evolutionary origins. Eur Arch Psychiatry Clin Neurosci. 1995;245(2):61–9. DOI: https://doi.org/10.1007/BF02190732 56. Cannon TD, Rosso IM, Bearden CE, et al. A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia. Dev Psychopathol. 1999;11(3):467–85. DOI: https://doi.org/10.1017/s0954579499002163 57. Shimonova GN, Kalinina MA, Kozlovskaya GV. Mikrokatatonicheskie narusheniya ili myagkie nevrologicheskie znaki u detej rannego vozrasta s rasstrojstvami autisticheskogo spektra. Sovremennaya terapiya v psikhiatrii i nevrologii. 2020;(1):8–11. (In Russ.) 58. Meyer-Lindenberg A. Autismusspektrumstörungen [Autism spectrum disorders]. Nervenarzt. 2011;82(5):551–2. DOI: https://doi.org/10.1007/s00115-010-3236-9 59. MacNeil LK, Mostofsky SH. Specificity of dyspraxia in children with autism. Neuropsychology. 2012;26(2):165–71. DOI: https://doi/org/10.1037/a0026955 60. Gorunova AV. Nevrologicheskie markery predraspolozhennosti k shizofrenii u detej rannego vozrasta. Psikhiatriya. 2007;(5):19–24. (In Russ.) 61. D'Agati E, Pitzianti M, Curatolo P, Pasini A. Scientific Evidence for the Evaluation of Neurological Soft Signs as Atypical Neurodevelopment Markers in Childhood Neuropsychiatric Disorders. J Psychiatr Pract. 2018;24(4):230–8. DOI: https://doi.org/10.1097/PRA.0000000000000312 62. Griffiths TD, Sigmundsson T, Takei N, et al. Neurological abnormalities in familial and sporadic schizophrenia. Brain. 1998;121(Pt 2):191–203. DOI: https://doi.org/10.1093/brain/121.2.191 63. Fish B, Marcus J, Hans SL, et al. Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry. 1992;49(3):221–35. DOI: https://doi.org/10.1001/archpsyc.1992.01820030053007 64. Johnstone EC, Macmillan JF, Frith CD, et al. Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry. 1990;157:182–9. DOI: https://doi.org/10.1192/bjp.157.2.182 65. Dazzan P, Morgan KD, Orr KG, et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain. 2004;127(Pt 1):143–53. DOI: https://doi.org/10.1093/brain/awh015 66. Mosher LR, Pollin W, Stabenau JR. Identical twins discordant for schizophrenia. Neurologic findings. Arch Gen Psychiatry. 1971;24(5):422–30. DOI: https://doi.org/10.1001/archpsyc.1971.01750110034006 67. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci. 1995;3(2):89–97. PMID: 7583624 68. Kong L, Cui H, Zhang T, et al. Neurological soft signs and grey matter abnormalities in individuals with ultra-high risk for psychosis. Psych J. 2019;8(2):252–60. DOI: https://doi.org/10.1002/pchj.258 69. Bechter K. Virus infection as a cause of inflammation in psychiatric disorders. Mod Trends Pharmacopsychiatry. 2013;28:49–60. DOI: https://doi.org/10.1159/000343967 70. Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol. 2012;72(10):1272–6. DOI: https://doi.org/10.1002/dneu.22024 71. Müller N. Immunological aspects of the treatment of depression and schizophrenia. Dialogues Clin Neurosci. 2017;19(1):55–63. DOI: https://doi.org/10.31887/DCNS.2017.19.1/nmueller 72. Arias I, Sorlozano A, Villegas E, et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res. 2012;136(1–3):128–36. DOI: https://doi.org/10.1016/j.schres.2011.10.026 73. Khandaker GM, Cousins L, Deakin J, et al. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2(3):258–70. DOI: https://doi.org/10.1016/S2215-0366(14)00122-9 74. Sutterland AL, Fond G, Kuin A, et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand. 2015;132(3):161–79. DOI: https://doi.org/10.1111/acps.12423 75. Klyushnik TP, Smulevich AB, Zozulya SA, Voronova EI. [Neurobiology of Schizophrenia (to the Construction of Clinical and Biological Model)]. Psikhiatriya. 2021;19(1):6–15. (In Russ.) DOI: https://doi.org/10.30629/2618-6667-2021-19-1-6-15
DOI: http://dx.doi.org/10.47877/1560-957Х-2022-10506
Метрики статей
Metrics powered by PLOS ALM